170 related articles for article (PubMed ID: 12171796)
1. Vitamin C and E intake is associated with increased paraoxonase activity.
Jarvik GP; Tsai NT; McKinstry LA; Wani R; Brophy VH; Richter RJ; Schellenberg GD; Heagerty PJ; Hatsukami TS; Furlong CE
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1329-33. PubMed ID: 12171796
[TBL] [Abstract][Full Text] [Related]
2. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity.
Tomás M; Sentí M; Elosua R; Vila J; Sala J; Masià R; Marrugat J
Eur J Pharmacol; 2001 Dec; 432(2-3):121-8. PubMed ID: 11740946
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 (PON1) is present in postprandial chylomicrons.
Fuhrman B; Volkova N; Aviram M
Atherosclerosis; 2005 May; 180(1):55-61. PubMed ID: 15823275
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and atherosclerosis.
Durrington PN; Mackness B; Mackness MI
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):473-80. PubMed ID: 11304460
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene.
Sentí M; Aubó C; Tomás M
Metabolism; 2000 May; 49(5):557-9. PubMed ID: 10831161
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
8. No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease.
Dalgård C; Christiansen L; Jonung T; Mackness MI; de Maat MP; Hørder M
Eur J Nutr; 2007 Sep; 46(6):354-63. PubMed ID: 17712585
[TBL] [Abstract][Full Text] [Related]
9. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.
Jarvik GP; Rozek LS; Brophy VH; Hatsukami TS; Richter RJ; Schellenberg GD; Furlong CE
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2441-7. PubMed ID: 11073850
[TBL] [Abstract][Full Text] [Related]
11. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
Sutherland WH; de Jong SA; Walker RJ
Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
[TBL] [Abstract][Full Text] [Related]
12. The hunt for nutritional and pharmacological modulators of paraoxonase.
Durrington PN; Mackness B; Mackness MI
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1248-50. PubMed ID: 12171781
[No Abstract] [Full Text] [Related]
13. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
Sentí M; Tomás M; Marrugat J; Elosua R;
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
[TBL] [Abstract][Full Text] [Related]
14. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.
Jaouad L; Milochevitch C; Khalil A
Free Radic Res; 2003 Jan; 37(1):77-83. PubMed ID: 12653220
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
[TBL] [Abstract][Full Text] [Related]
17. Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.
Brophy VH; Jarvik GP; Richter RJ; Rozek LS; Schellenberg GD; Furlong CE
Pharmacogenetics; 2000 Jul; 10(5):453-60. PubMed ID: 10898114
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
19. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease.
MacKness B; Mackness MI; Durrington PN; Arrol S; Evans AE; McMaster D; Ferrières J; Ruidavets JB; Williams NR; Howard AN
Eur J Clin Invest; 2000 Jan; 30(1):4-10. PubMed ID: 10619995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
